Dr. Allan Pantuck, Professor of Urology and head of the IUO Clinical Research Program, is co-author of a new study showing that use of the cancer drug sunitinib in an adjuvant setting may significantly reduce the risk of relapse in people with kidney cancer.
Media Release (PDF) >
A new imaging test, PSMA-PET, accurately detects prostate cancer cells throughout the body and better detects prostate cancer recurrences. UCLA is now the first medical center in Southern California to offer PSMA PET/CT imaging, which can detect prostate-cancer cells anywhere in the body more accurately than traditional methods. Clinical Update (PDF) > | IUO News >
Be Part of a Clinical Study.
Active Clinical Trials >
View answers to frequently asked questions
Why Choose the UCLA Institute of Urologic Oncology? >